세계의 수액백 시장 예측(2025-2030년)

The IV Bags market is projected to grow from US$4.312 billion in 2025 to US$5.677 billion in 2030 at a CAGR of 5.66%.

IV bags are pouches containing fluids, electrolytes, vitamins, minerals, and glucose solutions among others which are used in administering necessary fluids and nutrients in the body. The demand for IV packs is witnessing positive growth fueled by the growing electrolyte depletion, lack of hydration, and malnutrition problems in individuals which has bolstered the need for liquid nutrients and alternatives to be injected into the human body.

Furthermore, IV packs are becoming progressively prevalent and favored alternatives for parenteral bundling due to their simple accessibility. The cost of an IV sack is roughly $1, which significantly contributes to the market's rising deals.

Moreover, car crashes are one of the leading causes of disability and death worldwide, resulting in up to 50 million injuries and 1.3 million fatalities annually. Across the globe, one in every four deaths is related to walking or bicycling, based on the World Health Organization. Fluid administration is therefore required due to the rising number of surgeries and accidents, which is anticipated to spur market expansion.

IV Bags Market Drivers

• Growing chronic disease prevalence is propelling the market demand.

Factors such as the rising prevalence of chronic diseases, the increased number of surgeries and road accidents, and the growing geriatric population are expected to drive market growth during the forecast period. For instance, according to the National Institute of Health in July 2022 stated that around 20% of individuals in western locales, such as North America and Europe, have gastroesophageal reflux illness (GERD) as of 2022. Besides, the predominance of GERD in the US extended from 18.1% to 27.8%

Furthermore, information from the Cancer Realities and Figures 2023 report demonstrates that 297,790 ladies in the US are expected to get an obtrusive breast cancer conclusion in 2023, up from 287,850 modern cases in 2022. Additionally, the same source states that in 2023, compared to 51,400 cases in 2022, approximately 55,720 women in the US are anticipated to receive a non-invasive (in situ) breast cancer diagnosis. Since cancer treatment deprives the body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, it is anticipated that the demand for IV bags will increase. It increases the need for patients to receive parenteral nutrition, which drives market expansion.

IV Bags Market geographical outlook

• North America will continue to be the dominant market shareholder during the forecast period.

Geographically, the IV bags market has been segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific.

During the forecast period, the North American region is estimated to hold a considerable market share fueled by the growing chronic disease prevalence in the major regional economies, followed by well-established healthcare infrastructure and an increase in the number of surgical procedures and hospital visits. According to the American Hospital Association, in 2022, the strength of hospitals in the United States stood at 6,129, whereas the total number of admissions in U.S. hospitals reached 34,011,386.

Likewise, the increase in the prevalence of surgical procedures has also propelled the market demand, for instance, according to the American Society of Plastic Surgeons, in 2023, the total number of surgical procedures reported was 1,575,244 which signified a 5% growth over figure reported in 2022. Additionally, as per the data provided by the Alberta government, in 2022, the total number of surgeries conducted stood at 292,500 which represented a 13,900 increase over the preceding year's surgical volume.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The IV Bags Market is analyzed into the following segments:

By Type

• PVC
• PP
• PE

By Capacity

• Less than 100 ml
• 100-250 ml
• 250-500 ml
• 500-1000 ml
• Above 1000 ml

By Chamber Type

• Single Chamber
• Multi-Chamber

By End-User

• Blood Banks
• Hospitals
• Ambulatory Services

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. IV BAGS MARKET BY TYPE

• 5.1. Introduction
• 5.2. PVC
• 5.3. PP
• 5.4. PE

6. IV BAGS MARKET BY CAPACITY

• 6.1. Introduction
• 6.2. Less than 100 ml
• 6.3. 100-250 ml
• 6.4. 250-500 ml
• 6.5. 500-1000 ml
• 6.6. Above 1000 ml

7. IV BAGS MARKET BY CHAMBER TYPE

• 7.1. Introduction
• 7.2. Single Chamber
• 7.3. Multi-Chamber

8. IV BAGS MARKET END-USER

• 8.1. Introduction
• 8.2. Blood Banks
• 8.3. Hospitals
• 8.4. Ambulatory Services

9. IV BAGS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Type
  • 9.2.2. By Capacity
  • 9.2.3. By Chamber Type
  • 9.2.4. By End-User
  • 9.2.5. By Country
    • 9.2.5.1. USA
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Type
  • 9.3.2. By Capacity
  • 9.3.3. By Chamber Type
  • 9.3.4. By End-User
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Type
  • 9.4.2. By Capacity
  • 9.4.3. By Chamber Type
  • 9.4.4. By End-User
  • 9.4.5. By Country
    • 9.4.5.1. Germany
    • 9.4.5.2. France
    • 9.4.5.3. United Kingdom
    • 9.4.5.4. Spain
    • 9.4.5.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Type
  • 9.5.2. By Capacity
  • 9.5.3. By Chamber Type
  • 9.5.4. By End-User
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. Israel
    • 9.5.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. By Type
  • 9.6.2. By Capacity
  • 9.6.3. By Chamber Type
  • 9.6.4. By End-User
  • 9.6.5. By Country
    • 9.6.5.1. China
    • 9.6.5.2. Japan
    • 9.6.5.3. South Korea
    • 9.6.5.4. India
    • 9.6.5.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Sippex
• 11.2. Kraton Corporation
• 11.3. Renolit Solmed
• 11.4. Alfa Laboratories
• 11.5. Polycine GmbH
• 11.6. Haemotronic S.P.A.
• 11.7. Hospira Inc.
• 11.8. Technoflex S.A.
• 11.9. The Metrix Company
• 11.10. Medicopack A/S
• 11.11. Wipak Group
• 11.12. Qosina Corporation